How many insider trades does FilingIQ track for JNJ?

FilingIQ tracks 1,291 Form 4 insider transactions for JNJ (JOHNSON & JOHNSON), covering filings from Jan 16, 2015 onwards. 136 of those were filed in the last 90 days.

Are JNJ insiders net buyers or net sellers?

Across the full Form 4 history for JNJ, 9 transactions (1%) were open-market purchases and 399 (31%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.

Where does JNJ insider data come from?

Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.

What sector is JNJ in?

JOHNSON & JOHNSON (JNJ) is classified in the Healthcare sector, specifically Drug Manufacturers - General, with a current market capitalisation of $593.70B.

JNJ insider trading

NYSE Healthcare

JOHNSON & JOHNSON — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.

Total Form 4 trades

1,291

Last 90 days

136

Buys / sells

1% / 31%

Market cap

$593.70B

About JOHNSON & JOHNSON

Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of a range of products in the healthcare field worldwide. It operates in two segments, Innovative Medicine and MedTech. The Innovative Medicine segment offers products for various therapeutic areas, such as oncology, immunology, neuroscience, pulmonary hypertension, infectious diseases, and cardiovascular and metabolism distributed through retailers, wholesalers, distributors, hospitals, and healthcare professionals for prescription use. The MedTech segment provides a portfolio of products used in the surgery, orthopedic, cardiovascular, and vision fields distributed through wholesalers, hospitals and retailers, and used in the professional fields by physicians, nurses, hospitals, eye care professionals and clinics. This segment also offers products and enabling technologies that support joint reconstruction, trauma, spine, sports related injuries, and others, as well as open, laparoscopic, and robotic surgical procedures; instrumentation, energy devices, stapling systems, wound closure, biosurgery products, and digital and robotic technologies; breast aesthetics and reconstruction; contact lenses under the ACUVUE brand; intraocular lenses for cataract surgery, and other products used in cataract and refractive procedures under the TECNIS brand. The company was founded in 1886 and is based in New Brunswick, New Jersey.

Company website: www.jnj.com

JNJ insider activity at a glance

FilingIQ has scored 1,291 insider transactions for JNJ since Jan 16, 2015. The most recent filing in our index is dated May 1, 2026.

Across the full history, 9 open-market purchases and 399 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on JNJ insider trades is 58.9/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

View live JNJ trades on FilingIQ Raw filings on SEC EDGAR

Latest JNJ Form 4 filings

Wolk Joseph J Exec VP, CFO

S Feb 17, 2026

Duato Joaquin CEO and Chairman of the Board

S Aug 22, 2025

Wolk Joseph J Exec VP, CFO

S Feb 7, 2025

Taubert Jennifer L EVP, WW Chair, Pharmaceuticals

S Feb 9, 2024

Fasolo Peter Exec VP, Chief HR Officer

S Jul 25, 2023

Most recent disclosures. Sign up to filter by score, transaction code, or insider role.

Other Healthcare tickers with recent insider activity

UTHR 1,098

UNITED THERAPEUTICS Corp

APLS 279

Apellis Pharmaceuticals, Inc.

KMDA 218

KAMADA LTD

BMY 185

BRISTOL MYERS SQUIBB CO

ADPT 184

Adaptive Biotechnologies Corp

GH 169

Guardant Health, Inc.

ISRG 166

INTUITIVE SURGICAL INC

VTRS 165

Viatris Inc

13F funds holding JNJ

VANGUARD GROUP INC

$34.37B · 0.8% of AUM

STATE STREET CORP (STT, STT-PG)

$25.10B · 1.5% of AUM

STATE FARM MUTUAL AUTOMOBILE INSURANCE CO

$5.60B · 5.9% of AUM

FRANKLIN RESOURCES INC (BEN)

$2.30B · 0.6% of AUM

AMERIPRISE FINANCIAL INC (AMP)

$1.98B · 0.7% of AUM

Politicians who have traded JNJ

Doggett, Lloyd

U.S. Rep. , TX · 218 trades

Kean, Thomas H.

U.S. Rep. , NJ · 136 trades

Axne, Cindy

U.S. Rep. , IA · 128 trades

Franklin, C. Scott

U.S. Rep. , FL · 101 trades

Gallagher, Michael John

U.S. Rep. , WI · 38 trades

Frequently asked

How many insider trades does FilingIQ track for JNJ?: FilingIQ tracks 1,291 Form 4 insider transactions for JNJ (JOHNSON & JOHNSON), covering filings from Jan 16, 2015 onwards. 136 of those were filed in the last 90 days.
Are JNJ insiders net buyers or net sellers?: Across the full Form 4 history for JNJ, 9 transactions (1%) were open-market purchases and 399 (31%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does JNJ insider data come from?: Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
What sector is JNJ in?: JOHNSON & JOHNSON (JNJ) is classified in the Healthcare sector, specifically Drug Manufacturers - General, with a current market capitalisation of $593.70B.

Methodology & sources

Every JNJ insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.